Literature DB >> 20529572

HLA-mismatched/haploidentical hematopoietic stem cell transplantation: a field in which Chinese doctors are making great contributions.

Xiao-jun Huang1.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20529572

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  5 in total

Review 1.  Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.

Authors:  Xiaodong Mo; Xiaojun Huang
Journal:  Front Med       Date:  2013-07-20       Impact factor: 4.592

2.  Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study.

Authors:  J Chen; R-X Wang; F Chen; A-N Sun; H-Y Qiu; Z-M Jin; X-W Tang; Y Han; Z-Z Fu; G-S He; M Miao; X Ma; D-P Wu
Journal:  Bone Marrow Transplant       Date:  2013-10-21       Impact factor: 5.483

3.  Long-term outcome of HLA-haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion based on an FBCA conditioning regimen for hematologic malignancies.

Authors:  X Lin; Z G Lu; C Y Song; Y X Huang; K Y Guo; L Deng; S F Tu; Y Z He; J H Xu; H Long; B Y Wu
Journal:  Bone Marrow Transplant       Date:  2015-05-11       Impact factor: 5.483

4.  Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases.

Authors:  Limin Liu; Yanming Zhang; Wenjing Jiao; Huifen Zhou; Qingyuan Wang; Huiying Qiu; Xiaowen Tang; Yue Han; Chengcheng Fu; Zhengming Jin; Suning Chen; Aining Sun; Miao Miao; Depei Wu
Journal:  Bone Marrow Transplant       Date:  2020-03-26       Impact factor: 5.483

5.  Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study

Authors:  Xian-Fu Sheng; Hui Li; Li-Li Hong; Haifeng Zhuang
Journal:  Turk J Haematol       Date:  2022-04-22       Impact factor: 2.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.